Portfolio company
Orexo AB
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This pharmaceutical company develops improved medications and digital therapies for patients with opioid use disorder, cancer pain and insomnia.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Opiant
This company develops pharmacological treatments for substance use, addictive and eating disorders for patients and healthcare providers.
Egalet
This pharmaceutical company develops and commercialises abuse-deterrent oral medicines to treat acute and chronic pain for patients and healthcare providers.
Oncopeptides AB
This biotech company develops targeted therapies for patients with difficult-to-treat hematological diseases, specifically focusing on multiple myeloma treatments.
PainReform
This pharmaceutical company develops extended-release anesthetic formulations to provide post-operative pain relief for surgical patients and reduce opioid dependency.
Pleo Pharma
This pharmaceutical company develops oral treatments to mitigate cannabis withdrawal symptoms for adult patients with cannabis use disorder.
Centessa Pharmaceuticals
The company develops orexin receptor agonists for patients with sleep-wake disorders, neurological conditions and neuropsychiatric diseases.
Latigo Biotherapeutics
This clinical-stage biopharmaceutical company develops non-opioid medicines to treat patients suffering from pain without the risk of addiction.
Latigo
This clinical-stage biopharmaceutical company develops non-opioid medicines to treat acute and chronic pain for patients needing alternatives to addictive painkillers.